CY1114363T1 - Ανθελμινθικος συνδυασμος - Google Patents

Ανθελμινθικος συνδυασμος

Info

Publication number
CY1114363T1
CY1114363T1 CY20131100683T CY131100683T CY1114363T1 CY 1114363 T1 CY1114363 T1 CY 1114363T1 CY 20131100683 T CY20131100683 T CY 20131100683T CY 131100683 T CY131100683 T CY 131100683T CY 1114363 T1 CY1114363 T1 CY 1114363T1
Authority
CY
Cyprus
Prior art keywords
deoxoparaquamide
anthelmintic
anthelmintic combination
combination
avamectin
Prior art date
Application number
CY20131100683T
Other languages
English (en)
Inventor
Timothy G Geary
Peter Rolfe
Original Assignee
Zoetis Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zoetis Llc filed Critical Zoetis Llc
Publication of CY1114363T1 publication Critical patent/CY1114363T1/el

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/498—Pyrazines or piperazines ortho- and peri-condensed with carbocyclic ring systems, e.g. quinoxaline, phenazine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/4995—Pyrazines or piperazines forming part of bridged ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/10—Anthelmintics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/14—Ectoparasiticides, e.g. scabicides

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Παρέχεται μία μέθοδος για τη θεραπεία παρασιτικών μολύνσεων σε θηλαστικά, που περιλαμβάνει το στάδιο της ταυτόχρονης ή διαδοχικής χορήγησης στο θηλαστικό αποτελεσματικών ποσοτήτων (α) 2-δεσοξοπαραερκουαμιδίου, και (Β) αβαμηκτίνης. Επίσης παρέχεται μία ανθελμινθική σύνθεση που περιέχει 2-δεσοξοπαραερκουαμίδιο και αβαμηκτίνη.
CY20131100683T 2007-06-29 2013-08-09 Ανθελμινθικος συνδυασμος CY1114363T1 (el)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US94701507P 2007-06-29 2007-06-29
EP08762949.9A EP2170321B1 (en) 2007-06-29 2008-06-16 Anthelmintic combination

Publications (1)

Publication Number Publication Date
CY1114363T1 true CY1114363T1 (el) 2016-08-31

Family

ID=39831661

Family Applications (1)

Application Number Title Priority Date Filing Date
CY20131100683T CY1114363T1 (el) 2007-06-29 2013-08-09 Ανθελμινθικος συνδυασμος

Country Status (17)

Country Link
US (1) US8440633B2 (el)
EP (1) EP2170321B1 (el)
JP (1) JP5462456B2 (el)
CN (1) CN101686962B (el)
AR (1) AR067347A1 (el)
AU (1) AU2008272646B2 (el)
BR (1) BRPI0813235B1 (el)
CA (1) CA2690111C (el)
CY (1) CY1114363T1 (el)
DK (1) DK2170321T3 (el)
ES (1) ES2423505T3 (el)
NZ (1) NZ581859A (el)
PL (1) PL2170321T3 (el)
PT (1) PT2170321E (el)
TW (1) TWI352592B (el)
WO (1) WO2009004432A1 (el)
ZA (1) ZA201000672B (el)

Families Citing this family (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2009313920B2 (en) 2008-11-14 2014-10-23 Boehringer Ingelheim Animal Health USA Inc. Enantiomerically enriched aryloazol- 2 -yl cyanoethylamino paraciticidal compounds
MX2011005184A (es) 2008-11-19 2011-07-28 Merial Ltd Composiciones que comprenden un aril pirazol y/o una formamidina, metodos y usos de las mismas.
BRPI0922709B8 (pt) 2008-12-04 2017-03-14 Merial Ltd derivados diméricos de avermectina e milbemicina
ES2546100T3 (es) 2009-12-04 2015-09-18 Merial, Inc. Compuestos pesticidas bis-organosulfurados
BR112012014921B1 (pt) 2009-12-17 2020-11-03 Merial, Inc. compostos dihidroazol parasiticidas e composições compreendendo os mesmos
MX2012006921A (es) 2009-12-17 2012-07-10 Merial Ltd Composiciones que comprenden compuestos de lactona macrociclica y espirodioxepinoindoles.
UA108641C2 (uk) 2010-04-02 2015-05-25 Паразитицидна композиція, яка містить чотири активних агенти, та спосіб її застосування
NZ610547A (en) 2010-11-16 2015-07-31 Merial Ltd Novel monensin derivatives for the treatment and prevention of protozoal infections
JP6041359B2 (ja) 2011-06-27 2016-12-07 メリアル インコーポレイテッド アミドピリジルエーテル化合物及び組成物並びに寄生虫に対するそれらの使用
WO2013003168A1 (en) 2011-06-27 2013-01-03 Merial Limited Novel insect-repellent coumarin derivatives, syntheses, and methods of use
CA2848317C (en) 2011-09-12 2021-01-19 Merial Limited Parasiticidal compositions comprising an isoxazoline active agent, methods and uses thereof.
WO2013044118A2 (en) 2011-09-23 2013-03-28 Merial Limited Indirect modeling of new repellent molecules active against insects, acarids, and other arthropods
WO2013074892A1 (en) 2011-11-17 2013-05-23 Merial Limited Compositions comprising an aryl pyrazole and a substituted imidazole, methods and uses thereof
CA2857958C (en) 2011-12-02 2020-08-25 Merial Limited Long-acting injectable moxidectin formulations and moxidectin crystal forms
AU2013217633B2 (en) 2012-02-06 2017-01-12 Boehringer Ingelheim Animal Health USA Inc. Parasiticidal oral veterinary compositions comprising systemically-acting active agents, methods and uses thereof
JO3626B1 (ar) 2012-02-23 2020-08-27 Merial Inc تركيبات موضعية تحتوي على فيبرونيل و بيرميثرين و طرق استخدامها
EP3763706A1 (en) 2012-04-20 2021-01-13 Boehringer Ingelheim Animal Health USA Inc. Parasiticidal compositions comprising benzimidazole derivatives, methods and uses thereof
JP6506694B2 (ja) 2012-11-20 2019-04-24 メリアル インコーポレイテッド 駆虫性化合物及び組成物並びにこれらの使用方法
EP3063144B1 (en) 2013-11-01 2021-09-08 Boehringer Ingelheim Animal Health USA Inc. Antiparasitic and pesticidal isoxazoline compounds
EP3131398B1 (en) 2014-04-17 2019-10-23 Boehringer Ingelheim Animal Health USA Inc. Use of malononitrile compounds for protecting animals from parasites
US10045979B2 (en) 2014-05-19 2018-08-14 Merial Inc. Anthelmintic compounds
EA030459B1 (ru) 2014-06-19 2018-08-31 Мериал, Инк. Паразитицидные композиции, содержащие индольные производные, способы их получения и их применение
NZ731446A (en) 2014-10-31 2018-09-28 Boehringer Ingelheim Animal Health Usa Inc Parasiticidal composition comprising fipronil
UY36570A (es) 2015-02-26 2016-10-31 Merial Inc Formulaciones inyectables de acción prolongada que comprenden un agente activo isoxazolina, métodos y usos de las mismas
BR112017024773A2 (pt) 2015-05-20 2018-11-06 Merial, Inc. compostos depsipeptídeos anti-helmínticos
UY37137A (es) 2016-02-24 2017-09-29 Merial Inc Compuestos antiparasitarios de isoxazolina, formulaciones inyectables de acción prolongada que los comprenden, métodos y usos de los mismos
WO2018039508A1 (en) 2016-08-25 2018-03-01 Merial, Inc. Method for reducing unwanted effects in parasiticidal treatments
AU2017344097A1 (en) 2016-10-14 2019-05-02 Boehringer Ingelheim Animal Health USA Inc. Pesticidal and parasiticidal vinyl isoxazoline compounds
WO2018093920A1 (en) 2016-11-16 2018-05-24 Merial, Inc. Anthelmintic depsipeptide compounds
US11589586B2 (en) 2017-08-14 2023-02-28 Boehringer Ingelheim Animal Health USA Inc. Pesticidal and parasiticidal pyrazole-isoxazoline compounds
WO2019157241A1 (en) 2018-02-08 2019-08-15 Boehringer Ingelheim Animal Health USA Inc. Parasiticidal compositions comprising eprinomectin and praziquantel, methods and uses thereof
US20220048903A1 (en) 2018-07-09 2022-02-17 Boehringer Ingelheim Animal Health USA Inc. Anthelminthic Heterocyclic Compounds
AR116524A1 (es) * 2018-10-04 2021-05-19 Elanco Tiergesundheit Ag Potenciación de tratamiento de helmintos
EP3883648A1 (en) 2018-11-20 2021-09-29 Boehringer Ingelheim Animal Health USA Inc. Indazolylcyanoethylamino compound, compositions of same, method of making, and methods of using thereof
CA3129329A1 (en) 2019-03-01 2020-09-10 Boehringer Ingelheim Animal Health USA Inc. Injectable clorsulon compositions, methods and uses thereof
WO2020191091A1 (en) 2019-03-19 2020-09-24 Boehringer Ingelheim Animal Health USA Inc. Anthelmintic aza-benzothiophene and aza-benzofuran compounds
BR112022024156A2 (pt) 2020-05-29 2023-02-14 Boehringer Ingelheim Animal Health Usa Inc Compostos heterocílicos antelmínticos
EP4262789A1 (en) 2020-12-21 2023-10-25 Boehringer Ingelheim Vetmedica GmbH Parasiticidal collar comprising isoxazoline compounds
US20230312207A1 (en) 2022-02-17 2023-10-05 Boehringer Ingelheim Vetmedica Gmbh Method and system for providing a fluid product mailer

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ207655A (en) * 1983-04-07 1986-09-10 Merck & Co Inc Synergistic veterinary compositions containing an avermectin compound and clorsulon
GB2221621A (en) * 1988-08-12 1990-02-14 Merck & Co Inc Synergistic antiparasitic combinations of avermectin and pyrantel
PE20011289A1 (es) 2000-04-07 2001-12-21 Upjohn Co Composiciones antihelminticas que comprenden lactonas macrociclicas y espirodioxepinoindoles
AU2003900505A0 (en) * 2003-02-05 2003-02-20 Jurox Pty Ltd Anthelmintic composition

Also Published As

Publication number Publication date
TW200918044A (en) 2009-05-01
BRPI0813235A2 (pt) 2014-12-23
JP2009051820A (ja) 2009-03-12
BRPI0813235B1 (pt) 2019-01-22
CN101686962B (zh) 2012-05-23
PT2170321E (pt) 2013-08-01
ZA201000672B (en) 2010-10-27
AU2008272646A1 (en) 2009-01-08
NZ581859A (en) 2012-06-29
CN101686962A (zh) 2010-03-31
DK2170321T3 (da) 2013-07-29
TWI352592B (en) 2011-11-21
EP2170321B1 (en) 2013-05-22
WO2009004432A1 (en) 2009-01-08
JP5462456B2 (ja) 2014-04-02
US8440633B2 (en) 2013-05-14
US20100197624A1 (en) 2010-08-05
AU2008272646B2 (en) 2013-08-22
CA2690111A1 (en) 2009-01-08
AR067347A1 (es) 2009-10-07
ES2423505T3 (es) 2013-09-20
EP2170321A1 (en) 2010-04-07
PL2170321T3 (pl) 2013-12-31
CA2690111C (en) 2011-11-15

Similar Documents

Publication Publication Date Title
CY1114363T1 (el) Ανθελμινθικος συνδυασμος
CY1122812T1 (el) Δοσολογικο σχημα για εναν αγωνιστη του υποδοχεα s1p
CY1121125T1 (el) Συνθεσεις για τη θεραπευτικη αντιμετωπιση του πονου και/ή της φλεγμονης
CO6511251A2 (es) Compuestos quimicos
CY1122366T1 (el) Θεραπεια της οξειας λεμφοβλαστικης λευχαιμιας
CY1118017T1 (el) Υποβαλλοντας σε αγωγη την ανεπαρκεια και το ελλειμμα βιταμινης d με 25-υδροξυβιταμινη d2 και 25-υδροξυβιταμινη d3
CL2008003406A1 (es) Compuestos derivados de quinolina; composicion farmaceutica que los comprende; y uso en el tratamiento de una infeccion por vih.
ECSP088676A (es) Pirazolquinolonas como potentes inhibidores de parp
CY1120690T1 (el) Κρυσταλλικη μορφη βενζυλοβενζολικου αναστολεα τουsglt2
CO6480977A2 (es) Agonistas de gpr119
CL2011000691A1 (es) Compuestos derivados de nicotinamida sustituida; composicion farmaceutica que los comprende; uso para el tratamiento y/o prevencion de cancer, infecciones, enfermedades inflamatorias y autoinmunitarias.
CY1110989T1 (el) Χρηση 3-(4-αμινο-1-οξο-1,3-διυδρο-ισοϊνδολ-2-υλο)-πιπεριδινο-2,6-διονης για την αντιμετωπιση λεμφωματων κυτταρων του μανδυα
CR11626A (es) Inhibidores de beta-lactamasa
ECSP077182A (es) Metodos para el tratamiento de infecciones endobronquiales
CL2008002228A1 (es) Compuestos derivados de imidazopiridinonas, agonista de tlr7; procedimiento de preparacion; compuestos intermediarios; composiicon farmaceutica que los comprende; y uso en infecciones virales, bacterianas y fungicas.
ECSP099634A (es) Derivados de piridazinona útiles como inhibidores de glucano sintasa
ECSP10010413A (es) Inhibidores macrociclicos de serina proteasa
CL2011000957A1 (es) Compuesto derivados de isoindolina sustituidos, inhibidores de citosinas tnf-a; composicion farmaceutica; utiles en el tratamiento del cancer.
CL2011000589A1 (es) Compuestos derivados de pirrolidin-2-carboxamida, inhibidores de la interaccion p53-mdm2; composicion farmaceutica que los comprende; y su uso en la preparacion de medicamentos utiles para el tratamiento del cancer.
DOP2006000268A (es) Agentes antibacterianos
CR11290A (es) Derivados de ciclopropilamida
UY31860A (es) Piridinas de tiazolo como inhibidoras de la adn girasa
CL2009000402A1 (es) Compuestos derivados de 2-amino-acetamida sustituida; composicion farmaceutica; utiles en el tratamiento de enfermedades pulmonares, enfermedad reumatica, enfermedad autoinmune, entre otras.
GT200500246A (es) Combinacion de compuestos organicos
UY30158A1 (es) Uso de derivados de benzo-heteroaril sulfamida para el tratamiento del dolor